ReviewAmerican journal of translational research2021

Cholangiocarcinoma: the role of genetic and epigenetic factors; current and prospective treatment with checkpoint inhibitors and immunotherapy.

Panagiotis Sarantis et al.PubMed ↗Full text ↗

No numbers read from the abstract.